Optimum inspiratory conditions of targeting therapy of the upper airways for anti-influenza virus inhalers

Pharmacology, Toxicology and Pharmaceutical Science

• Influenza Virus 100%
• Particle-Size Distribution 100%
• Drug Delivery 100%
• Relenza 50%
• Seasonal Influenza 50%
• Upper Respiratory Tract Infection 50%
• Dry Powder Inhaler 50%
• Drug 50%
• Laninamivir Octanoate 50%